“ TULSA should be presented as an option to every patient as part of informed consent. If I don’t tell someone about TULSA, I wouldn’t be doing my job.”
Y. Mark Hong, MD 
The TULSA Procedure is a radiation-free, incision-free, minimally invasive procedure. It is a customized procedure that is personalized based on the patient’s unique anatomy and prostate disease. Precise physician planning before the procedure and active urethral and rectal cooling during the procedure enables the physician to avoid and protect critical structures around the prostate, minimizing the risk of side effects.
of men
Reported preservation of erectile function at 1 to 2 years1
of men
Reported preservation of continence and were pad-free at 1 to 2 years1
of men
Previously potent
patients reported
erection firmness
sufficient for
penetration by 5 years5
of men
Reported maintenance of urinary continence at 5 years 5
1. Lumiani, et al. “Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA)” Urologic Oncology (2021)
2. Klotz, et al. “MP46-03-Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Three-year follow-up”. The Journal of Urology Suppl (2021)
3. Klotz, Laurence. “MRI-Guided Transurethral Ultrasound Ablation (TULSA): Not just another focal therapy.” September 2022, PowerPoint Presentation.
4. Pavlovich, et al. “MP73-05-Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Four-year follow-up”. The Journal of Urology Suppl (2023)
5. PRO-TALK Webinar, Episode 5, “Unlocking the Potential for TULSA-PRO: Embrace the Future Now and Avoid Being Left Behind”. June 2023. https://youtu.be/MQY9oxdU59E
“ TULSA should be presented as an option to every patient as part of informed consent. If I don’t tell someone about TULSA, I wouldn’t be doing my job.”
Y. Mark Hong, MD “ After four years, erectile and urinary functional outcomes continue to contrast positively with radical prostatectomy and radiation therapy.”
Laurence Klotz, MD, FRCSC, CM